{"DataElement":{"publicId":"7662130","version":"1","preferredName":"Findings About Events or Interventions Domain Imaging Technique Tracer Avidity Tracer Avidity Type","preferredDefinition":"Term that represents the kind of tracer avidity that was used during imaging.","longName":"SUPPFA_QVAL_FATRCRAVDTYP","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"7662124","version":"1","preferredName":"Findings About Events or Interventions Domain Imaging Technique Tracer Avidity","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to findings about events or interventions._Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy._A substance that is identifiable by virtue of its radioactive signature, color, or other distinguishing physical property, such as a dye, radioactive isotope, or inert chemical, that is introduced into a biological or mechanical system and can be followed through the course of a process, providing information on the pattern of events in the process or on the redistribution of the parts, elements, or events involved._Strength of binding, usually of a small molecule with multiple binding sites by a larger, particularly the binding of a complex antigen by an antibody.","longName":"6407857v1.0:7662122v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6407857","version":"1","preferredName":"Findings About Events or Interventions Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to findings about events or interventions.","longName":"C85442","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Findings About Events or Interventions Domain","conceptCode":"C85442","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to findings about events or interventions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"73F5798C-4173-2710-E053-F662850A3FB0","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7662122","version":"1","preferredName":"Imaging Technique Tracer Avidity","preferredDefinition":"Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.:A substance that is identifiable by virtue of its radioactive signature, color, or other distinguishing physical property, such as a dye, radioactive isotope, or inert chemical, that is introduced into a biological or mechanical system and can be followed through the course of a process, providing information on the pattern of events in the process or on the redistribution of the parts, elements, or events involved.:Strength of binding, usually of a small molecule with multiple binding sites by a larger, particularly the binding of a complex antigen by an antibody.","longName":"C17369:C2480:C16297","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Imaging Technique","conceptCode":"C17369","definition":"Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Tracer","conceptCode":"C2480","definition":"A substance that is identifiable by virtue of its radioactive signature, color, or other distinguishing physical property, such as a dye, radioactive isotope, or inert chemical, that is introduced into a biological or mechanical system and can be followed through the course of a process, providing information on the pattern of events in the process or on the redistribution of the parts, elements, or events involved.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Avidity","conceptCode":"C16297","definition":"Strength of binding, usually of a small molecule with multiple binding sites by a larger, particularly the binding of a complex antigen by an antibody.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C24D40FB-ACED-1C8B-E053-4EBD850AA819","latestVersionIndicator":"Yes","beginDate":"2021-05-14","endDate":null,"createdBy":"CARPIOJ","dateCreated":"2021-05-14","modifiedBy":"ONEDATA","dateModified":"2021-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C24D40FB-ACFE-1C8B-E053-4EBD850AA819","latestVersionIndicator":"Yes","beginDate":"2021-05-14","endDate":null,"createdBy":"CARPIOJ","dateCreated":"2021-05-14","modifiedBy":"CARPIOJ","dateModified":"2021-06-18","changeDescription":"5/14/2021 - Curated for PEPN2011","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7662120","version":"1","preferredName":"Tracer Avidity Type","preferredDefinition":"A substance that is identifiable by virtue of its radioactive signature, color, or other distinguishing physical property, such as a dye, radioactive isotope, or inert chemical, that is introduced into a biological or mechanical system and can be followed through the course of a process, providing information on the pattern of events in the process or on the redistribution of the parts, elements, or events involved._Strength of binding, usually of a small molecule with multiple binding sites by a larger, particularly the binding of a complex antigen by an antibody._Something distinguishable as an identifiable class based on common qualities.","longName":"7662120v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other, specify:","valueDescription":"Other Specify","ValueMeaning":{"publicId":"4188777","version":"1","preferredName":"Other Specify","longName":"4188777","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Be specific about something; define clearly.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F3CC9DDB-CE4D-9879-E040-BB89AD430A03","latestVersionIndicator":"Yes","beginDate":"2014-03-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C24D40FB-ACA3-1C8B-E053-4EBD850AA819","beginDate":"2021-05-14","endDate":null,"createdBy":"CARPIOJ","dateCreated":"2021-05-14","modifiedBy":"ONEDATA","dateModified":"2021-05-14","deletedIndicator":"No"},{"value":"FDG-PET","valueDescription":"FDG-Positron Emission Tomography","ValueMeaning":{"publicId":"7662121","version":"1","preferredName":"FDG-Positron Emission Tomography","longName":"7662121","preferredDefinition":"An imaging technique that utilizes positron emission tomography to produce a three-dimensional image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on the biologically active molecule (fludeoxyglucose) FDG. FDG is an analogue of glucose which when imaged will give tissue metabolic activity, in terms of regional glucose uptake.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FDG-Positron Emission Tomography","conceptCode":"C103400","definition":"An imaging technique that utilizes positron emission tomography to produce a three-dimensional image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on the biologically active molecule (fludeoxyglucose) FDG. FDG is an analogue of glucose which when imaged will give tissue metabolic activity, in terms of regional glucose uptake.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C24D40FB-ACAF-1C8B-E053-4EBD850AA819","latestVersionIndicator":"Yes","beginDate":"2021-05-14","endDate":null,"createdBy":"CARPIOJ","dateCreated":"2021-05-14","modifiedBy":"ONEDATA","dateModified":"2021-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C24D40FB-ACC8-1C8B-E053-4EBD850AA819","beginDate":"2021-05-14","endDate":null,"createdBy":"CARPIOJ","dateCreated":"2021-05-14","modifiedBy":"ONEDATA","dateModified":"2021-05-14","deletedIndicator":"No"},{"value":"I-MIBG","valueDescription":"Iodine I 131 Metaiodobenzylguanidine","ValueMeaning":{"publicId":"3585878","version":"1","preferredName":"Iodine I 131 Metaiodobenzylguanidine","longName":"3585878","preferredDefinition":"An I 131 radioiodinated synthetic analogue of the neurotransmitter norepinephrine. Meta-iodobenzylguanidine localizes to adrenergic tissue and, in radioiodinated forms, may be used to image or eradicate tumor cells that take up and metabolize norepinephrine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iobenguane I-131","conceptCode":"C970","definition":"An I 131 radioiodinated synthetic analogue of the neurotransmitter norepinephrine. Iobenguane localizes to adrenergic tissue and, in radioiodinated forms, may be used to image or eradicate tumor cells that take up and metabolize norepinephrine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C909F7AC-3A64-EE36-E040-BB89AD435E39","latestVersionIndicator":"Yes","beginDate":"2012-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-09-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C24D40FB-ACDD-1C8B-E053-4EBD850AA819","beginDate":"2021-05-14","endDate":null,"createdBy":"CARPIOJ","dateCreated":"2021-05-14","modifiedBy":"ONEDATA","dateModified":"2021-05-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7662119","version":"1","preferredName":"Tracer Avidity Type","preferredDefinition":"A substance that is identifiable by virtue of its radioactive signature, color, or other distinguishing physical property, such as a dye, radioactive isotope, or inert chemical, that is introduced into a biological or mechanical system and can be followed through the course of a process, providing information on the pattern of events in the process or on the redistribution of the parts, elements, or events involved.:Strength of binding, usually of a small molecule with multiple binding sites by a larger, particularly the binding of a complex antigen by an antibody.:Something distinguishable as an identifiable class based on common qualities.","longName":"C2480:C16297:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tracer","conceptCode":"C2480","definition":"A substance that is identifiable by virtue of its radioactive signature, color, or other distinguishing physical property, such as a dye, radioactive isotope, or inert chemical, that is introduced into a biological or mechanical system and can be followed through the course of a process, providing information on the pattern of events in the process or on the redistribution of the parts, elements, or events involved.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Avidity","conceptCode":"C16297","definition":"Strength of binding, usually of a small molecule with multiple binding sites by a larger, particularly the binding of a complex antigen by an antibody.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C24D40FB-AC7C-1C8B-E053-4EBD850AA819","latestVersionIndicator":"Yes","beginDate":"2021-05-14","endDate":null,"createdBy":"CARPIOJ","dateCreated":"2021-05-14","modifiedBy":"ONEDATA","dateModified":"2021-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C24D40FB-AC8D-1C8B-E053-4EBD850AA819","latestVersionIndicator":"Yes","beginDate":"2021-05-14","endDate":null,"createdBy":"CARPIOJ","dateCreated":"2021-05-14","modifiedBy":"CARPIOJ","dateModified":"2021-06-18","changeDescription":"5/14/2021 - Curated for PEPN2011","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What type of tracer avidity w","type":"Preferred Question Text","description":"What type of tracer avidity was used?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C24D40FB-AD6D-1C8B-E053-4EBD850AA819","latestVersionIndicator":"Yes","beginDate":"2021-05-14","endDate":null,"createdBy":"CARPIOJ","dateCreated":"2021-05-14","modifiedBy":"CARPIOJ","dateModified":"2021-06-18","changeDescription":"5/14/2021 - curated for PEPN2011.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}